Skip to main content

Table 2 Baseline characteristics of study 2 participants

From: Understanding patient activation and adherence to nebuliser treatment in adults with cystic fibrosis: responses to the UK version of PAM-13 and a think aloud study

  Baseline
Age
 Mean (SD) 29.7(11.5)
 Median (IQR) 27(21, 36)
Sex
 Male 36 (56%)
 Female 28 (44%)
FEV 1% Predicted
 Mean (SD) 57.3 (21.3)
 Median (IQR) 49.6 (41.9, 76.7)